Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20196454 | 0.79 | MAPT (0.37) | MAPTCA1CA2CA4CA7 | |
| SCHEMBL20683211 | 0.78 | MEN1 (0.32) | MAPT | |
| SCHEMBL26085343 | 0.78 | MAPT (0.32) | MAPT | |
| SCHEMBL26503650 | 0.77 | POLB (0.30) | MAPT | |
| SCHEMBL11497979 | 0.76 | — | — | |
| SCHEMBL21298846 | 0.73 | POLB (0.33) | MAPT | |
| SCHEMBL23565834 | 0.72 | MAPT (0.33) | MAPT | |
| SCHEMBL26529058 | 0.70 | MAPT (0.35) | MAPTCA1CA2CA4CA7 | |
| SCHEMBL25735085 | 0.69 | MAPT (0.31) | MAPT | |
| SCHEMBL21887534 | 0.68 | MAPT (0.30) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257827-A1 | CONJUGATES AND PREPARATION AND USE THEREOF | Suzhou Ribo Life Science Co., Ltd. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20200338201-A1 | CONJUGATES AND PREPARATION AND USE THEREOF | SUZHOU RIBO LIFE SCIENCE CO. LTD. (CN) | 2020-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200338201-A1 | CONJUGATES AND PREPARATION AND USE THEREOF | SLC10A1, GOT1, SLC19A1 | MAPT 3210/4885CA1 2019/4885CA2 4449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.